Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
DNMR
|
Live Oak Sponsor Partners, LLC |
BUY
Conversion of derivative security
|
Direct | 5,000,000 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Gary Kent Wunderlich Jr
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 5,000,000 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Gary Kent Wunderlich Jr
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,905,000 Added 50.0% |
$49,050,000
$10.0 p/Share
|
Dec 29
2020 |
|
DNMR
|
Stephen Croskrey |
SELL
Other acquisition or disposition
|
Direct | 944,144 Reduced 21.3% |
$22,848,286
$24.2 p/Share
|
Dec 29
2020 |
|
DNMR
|
Stephen Croskrey |
BUY
Grant, award, or other acquisition
|
Direct | 4,432,261 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
John Dowdy
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 303,054 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Stuart W Pratt |
BUY
Grant, award, or other acquisition
|
Indirect | 1,388,166 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Stuart W Pratt |
BUY
Grant, award, or other acquisition
|
Direct | 1,713,892 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Stuart W Pratt |
SELL
Other acquisition or disposition
|
Direct | 244,786 Reduced 14.28% |
$5,923,821
$24.2 p/Share
|
Dec 29
2020 |
|
DNMR
|
Scott Tuten
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 51,870 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Scott Tuten
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 146,192 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Phillip D Van Trump
Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 22,894 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Philip Gregory Calhoun |
BUY
Grant, award, or other acquisition
|
Indirect | 3,288,857 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Philip Gregory Calhoun |
BUY
Grant, award, or other acquisition
|
Direct | 236,878 Added 50.0% |
-
|
Dec 29
2020 |
|
DNMR
|
Isao Noda |
BUY
Grant, award, or other acquisition
|
Direct | 50,926 Added 50.0% |
-
|
Dec 29
2020 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.17% |
$1,032,450
$68.83 p/Share
|
Dec 29
2020 |
|
NPTN
|
Timothy Storrs Jenks
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 24,326 Added 4.8% |
$184,634
$7.59 p/Share
|
Dec 29
2020 |
|
PLAB
|
Peter S Kirlin
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 5.32% |
$126,400
$6.32 p/Share
|
Dec 29
2020 |
|
PLAB
|
Peter S Kirlin
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 11,975 Reduced 3.44% |
$131,366
$10.97 p/Share
|
Dec 29
2020 |
|
PLAB
|
Peter S Kirlin
Chief Executive Officer |
BUY
Open market or private sale
|
Direct | 1,029 Added 0.29% |
$11,556
$11.23 p/Share
|
Dec 29
2020 |
|
LXU
|
Michael J. Foster
EVP, General Counsel and Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 5,235 Reduced 1.96% |
$14,763
$2.82 p/Share
|
Dec 29
2020 |
|
LXU
|
Mark T Behrman
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,675 Reduced 1.47% |
$38,563
$2.82 p/Share
|
Dec 29
2020 |
|
ATRI
|
Preston G Athey
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 117 Reduced 18.9% |
$74,807
$639.38 p/Share
|
Dec 29
2020 |
|
ATRI
|
Ronald Nicholas Spaulding
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 117 Reduced 5.21% |
$74,807
$639.38 p/Share
|
Dec 29
2020 |
|
ATRI
|
John P Stupp Jr
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 117 Reduced 1.96% |
$74,807
$639.38 p/Share
|
Dec 29
2020 |
|
BKE
|
Dennis H Nelson
President & CEO |
SELL
Bona fide gift
|
Indirect | 300,000 Reduced 11.98% |
-
|
Dec 29
2020 |
|
BKE
|
Thomas B Heacock
SVP Finance, Treasurer, & CFO |
BUY
Bona fide gift
|
Indirect | 100,000 Added 50.0% |
-
|
Dec 29
2020 |
|
OSIS
|
Steven C Good |
SELL
Bona fide gift
|
Direct | 184 Reduced 1.11% |
-
|
Dec 29
2020 |
|
XHR
|
Marcel Verbaas
Director |
BUY
Grant, award, or other acquisition
|
Direct | 40,274 Added 5.02% |
-
|
Dec 29
2020 |
|
XHR
|
Taylor C. Kessel
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,747 Added 11.08% |
-
|
Dec 29
2020 |
|
XHR
|
Atish Shah
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,110 Added 9.09% |
-
|
Dec 29
2020 |
|
XHR
|
Barry A N Bloom
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,137 Added 21.03% |
-
|
Dec 29
2020 |
|
XHR
|
Joseph T Johnson
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,713 Added 13.31% |
-
|
Dec 29
2020 |
|
GSHD
|
Mark Evan Jones
Executive Chairman |
BUY
Conversion of derivative security
|
Indirect | 22,303 Added 50.0% |
-
|
Dec 29
2020 |
|
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Conversion of derivative security
|
Indirect | 22,303 Reduced 0.18% |
-
|
Dec 29
2020 |
|
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 22,303 Reduced 34.1% |
$2,722,304
$122.06 p/Share
|
Dec 29
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
BUY
Conversion of derivative security
|
Indirect | 22,303 Added 50.0% |
-
|
Dec 29
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Conversion of derivative security
|
Indirect | 22,303 Reduced 0.18% |
-
|
Dec 29
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Indirect | 22,303 Reduced 34.1% |
$2,722,304
$122.06 p/Share
|
Dec 29
2020 |
|
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 22,303 Added 50.0% |
-
|
Dec 29
2020 |
|
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
SELL
Conversion of derivative security
|
Direct | 22,303 Reduced 0.2% |
-
|
Dec 29
2020 |
|
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 22,303 Reduced 100.0% |
$2,722,304
$122.06 p/Share
|
Dec 29
2020 |
|
NOG
|
Chad W Allen
CFO |
BUY
Grant, award, or other acquisition
|
Direct | 16,073 Added 25.75% |
-
|
Dec 29
2020 |
|
NOG
|
Erik J. Romslo
Chief Legal Officer & Sec. |
BUY
Grant, award, or other acquisition
|
Direct | 20,666 Added 18.71% |
-
|
Dec 29
2020 |
|
NOG
|
Michael D. Kelly
Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,073 Added 33.72% |
-
|
Dec 29
2020 |
|
NOG
|
Adam A. Dirlam
President |
BUY
Grant, award, or other acquisition
|
Direct | 18,370 Added 23.55% |
-
|
Dec 29
2020 |
|
NOG
|
Nicholas L. O'Grady
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 55,109 Added 26.05% |
-
|
Dec 29
2020 |
|
NOG
|
Bahram Akradi
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,222 Added 1.0% |
-
|
Dec 29
2020 |
|
NOG
|
Michael T Popejoy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,444 Added 9.52% |
-
|
Dec 29
2020 |
|
NOG
|
Michael A Frantz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,444 Added 8.73% |
-
|
Dec 29
2020 |